5-(3-methyl-1,2,4-oxadiazol-5-yl)-1H-indole, 95.0%, 500mg

1,2-dimethyl-1H-pyrrole-3-carboxylic acid, 95.0%, 5g

(1S,3R)-2,2-Dimethyl-3-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]cyclobutane-1-carboxylic acid, 95+%, 250mg

Phenylethylisocyanide, 95.0%, 5g

N-(2,3,4-TRIFLUOROPHENYL)ACETAMIDE, 95.0%, 1g

DIPHENYL((PHENYLTHIO)METHYL)PHOSPHINE OXIDE, 95%, 250mg

(S)-1-(4-Bromophenyl)ethane-1,2-diol, 98%, 100mg

(S)-BENZYL 2-METHYL-4-OXOPIPERIDINE-1-CARBOXYLATE, 95.0%, 500mg

tert-butyl 4-hydroxy-4-(thiophen-2-yl)piperidine-1-carboxylate, 97%, 1g

1-(4-Bromophenyl)-2-hydroxyethanone, 95%, 10g

2-[2-oxo-2-(2,2,4-trimethyl-3,4-dihydroquinolin-1(2H)-yl)ethyl]-1H-isoindole-1,3(2H)-dione, 95.0%, 1g

Colonne capillaire GC ROTI®Cap-5, 15 m, 0,53 mm, 0,50 µm, 1 pièce(s)

4-Oxazolecarboxamide, 2-(2-chloro-6-fluorophenyl)-5-[[4-(4-morpholinylcarbonyl)phenyl]amino]-, 25mg